|
1
|
Basu RK, Chawla LS, Wheeler DS and
Goldstein SL: Renal angina: an emerging paradigm to identify
children at risk for acute kidney injury. Pediatr Nephrol.
27:1067–1078. 2012. View Article : Google Scholar :
|
|
2
|
Atabai K and Matthay MA: The pulmonary
physician in critical care. 5: Acute lung injury and the acute
respiratory distress syndrome: definitions and epidemiology.
Thorax. 57:452–458. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Raghavendran K and Napolitano LM:
Definition of ALI/ARDS. Crit Care Clin. 27:429–437. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chignard M and Balloy V: Neutrophil
recruitment and increased permeability during acute lung injury
induced by lipopolysaccharide. Am J Physiol Lung Cell Mol Physiol.
279:L1083–L1090. 2000.PubMed/NCBI
|
|
5
|
Shang Y, Li X, Prasad PV, Xu S, Yao S, Liu
D, Yuan S and Feng D: Erythropoietin attenuates lung injury in
lipopolysaccharide treated rats. J Surg Res. 155:104–110. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Diaz JV, Brower R, Calfee CS and Matthay
MA: Therapeutic strategies for severe acute lung injury. Crit Care
Med. 38:1644–1650. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Imai Y, Kuba K, Neely GG,
Yaghubian-Malhami R, Perkmann T, van Loo G, Ermolaeva M, Veldhuizen
R, Leung YH, Wang H, et al: Identification of oxidative stress and
Toll-like receptor 4 signaling as a key pathway of acute lung
injury. Cell. 133:235–249. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zambon M and Vincent JL: Mortality rates
for patients with acute lung injury/ARDS have decreased over time.
Chest. 133:1120–1127. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kitamura Y, Hashimoto S, Mizuta N,
Kobayashi A, Kooguchi K, Fujiwara I and Nakajima H:
Fas/FasL-dependent apoptosis of alveolar cells after
lipopolysaccharide-induced lung injury in mice. Am J Respir Crit
Care Med. 163:762–769. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Abraham E, Nick JA, Azam T, Kim SH, Mira
JP, Svetkauskaite D, He Q, Zamora M, Murphy J, Park JS, et al:
Peripheral blood neutrophil activation patterns are associated with
pulmonary inflammatory responses to lipopolysaccharide in humans. J
Immunol. 176:7753–7760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bhatia M and Moochhala S: Role of
inflammatory mediators in the pathophysiology of acute respiratory
distress syndrome. J Pathol. 202:145–156. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bouwmeester T, Bauch A, Ruffner H, Angrand
PO, Bergamini G, Croughton K, Cruciat C, Eberhard D, Gagneur J,
Ghidelli S, et al: A physical and functional map of the human
TNF-alpha/NF-kappa B signal transduction pathway. Nat Cell Biol.
6:97–105. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Auron PE: The interleukin 1 receptor:
Ligand interactions and signal transduction. Cytokine Growth Factor
Rev. 9:221–237. 1998. View Article : Google Scholar
|
|
14
|
Creager MA, Luscher TF, Cosentino F and
Beckman JA: Diabetes and vascular disease: pathophysiology,
clinical consequences, and medical therapy: Part I. Circulation.
108:1527–1532. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kagan JC and Medzhitov R:
Phosphoinositide-mediated adaptor recruitment controls Toll-like
receptor signaling. Cell. 125:943–955. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wilson SJ, Leone BA, Anderson D, Manning A
and Holgate ST: Immunohistochemical analysis of the activation of
NF-kappaB and expression of associated cytokines and adhesion
molecules in human models of allergic inflammation. J Pathol.
189:265–272. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Richmond A: NF-kappa B, chemokine gene
transcription and tumour growth. Nat Rev Immunol. 2:664–674. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Karin M and Ben-Neriah Y: Phosphorylation
meets ubiquitination: The control of NF-[kappa]B activity. Annu Rev
Immunol. 18:621–663. 2000. View Article : Google Scholar
|
|
19
|
Senthikumar A and Venkatesalu V:
Phytochemical analysis and antibacterial activity of essential oil
of Clausena anisata (Wild). Hook. F. ex Benth. Int J Intergrat
Biol. 5:116–120. 2009.
|
|
20
|
Ajibesin KK, Ekpo BA, Bala DN, Essien EE
and Adesanya SA: Ethnobotanical survey of Akwa Ibom State of
Nigeria. J Ethnopharmacol. 115:387–408. 2008. View Article : Google Scholar
|
|
21
|
Hutchings A, Scott AH, Lewis G and
Cunningham AB: Zulu Medicinal Plants – An Inventory. 1st edition.
University of Natal Press; Pietermaritzburg: 1996
|
|
22
|
Lakshmi V, Prakash D, Raj K, Kapil RS and
Popli SP: Monoterpenoid furanocoumarin lactones from Clausena
anisata. Phytochemistry. 23:2629–2631. 1984. View Article : Google Scholar
|
|
23
|
Adesina SK and Adewunmi CO: Molluscicidal
agents from the root of Clausena anisata. Fitoterapia. 56:289–292.
1985.
|
|
24
|
Makanju OO: Behavioral and anticonvulsant
effects of an aqueous extract from the roots of Clausena anisata.
Int J Crude Drug Res. 21:29–32. 1983. View Article : Google Scholar
|
|
25
|
Watt JM and Breyer Brandwijk MG: The
Medicinal and Poisonous Plants of Southern and Eastern Africa. 2nd
edition. E. and S. Livingstone; London: 1962
|
|
26
|
Ganter MT, Roux J, Miyazawa B, Howard M,
Frank JA, Su G, Sheppard D, Violette SM, Weinreb PH, Horan GS, et
al: Interleukin-1beta causes acute lung injury via alphavbeta5 and
alphavbeta6 integrin-dependent mechanisms. Circ Res. 102:804–812.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kolb M, Margetts PJ, Anthony DC, Pitossi F
and Gauldie J: Transient expression of IL-1β induces acute lung
injury and chronic repair leading to pulmonary fibrosis. J Clin
Invest. 107:1529–1536. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Giebelen IA, van Westerloo DJ, LaRosa GJ,
de Vos AF and van der Poll T: Local stimulation of alpha7
cholinergic receptors inhibits LPS-induced TNF-alpha release in the
mouse lung. Shock. 28:700–703. 2007.PubMed/NCBI
|
|
29
|
Matthay MA and Zimmerman GA: Acute lung
injury and the acute respiratory distress syndrome: Four decades of
inquiry into pathogenesis and rational management. Am J Respir Cell
Mol Biol. 33:319–327. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Scheller J, Chalaris A, Schmidt-Arras D
and Rose-John S: The pro- and anti-inflammatory properties of the
cytokine interleukin-6. Biochim Biophys Acta. 1813:878–888. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mukhopadhyay S, Hoidal JR and Mukherjee
TK: Role of TNFalpha in pulmonary pathophysiology. Respir Res.
7:1252006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang HZ, Wang JP, Mi S, Liu HZ, Cui B, Yan
HM, Yan J, Li Z, Liu H, Hua F, et al: TLR4 activity is required in
the resolution of pulmonary inflammation and fibrosis after acute
and chronic lung injury. Am J Pathol. 180:275–292. 2012. View Article : Google Scholar
|
|
33
|
Ghosh S and Hayden MS: New regulators of
NF-kappaB in inflammation. Nat Rev Immunol. 8:837–848. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fu Y, Liu B, Zhang N, Liu Z, Liang D, Li
F, Cao Y, Feng X, Zhang X and Yang Z: Magnolol inhibits
lipopolysaccharide-induced inflammatory response by interfering
with TLR4 mediated NF-κB and MAPKs signaling pathways. J
Ethnopharmacol. 145:193–199. 2013. View Article : Google Scholar
|
|
35
|
Moine P, McIntyre R, Schwartz MD, Kaneko
D, Shenkar R, Le Tulzo Y, Moore EE and Abraham E: NF-kappaB
regulatory mechanisms in alveolar macrophages from patients with
acute respiratory distress syndrome. Shock. 13:85–91. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Goodman RB, Pugin J, Lee JS and Matthay
MA: Cytokine-mediated inflammation in acute lung injury. Cytokine
Growth Factor Rev. 14:523–535. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kuo MY, Liao MF, Chen FL, Li YC, Yang ML,
Lin RH and Kuan YH: Luteolin attenuates the pulmonary inflammatory
response involves abilities of antioxidation and inhibition of MAPK
and NFκB pathways in mice with endotoxin-induced acute lung injury.
Food Chem Toxicol. 49:2660–2666. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Redington AE, Meng QH, Springall DR, Evans
TJ, Créminon C, Maclouf J, Holgate ST, Howarth PH and Polak JM:
Increased expression of inducible nitric oxide synthase and
cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects
and regulation by corticosteroid treatment. Thorax. 56:351–357.
2001. View Article : Google Scholar : PubMed/NCBI
|
